Global Information
-
Roche:Finding a new normal after breast cancer
2021-05-22
When Nicole turned 40, her best friend urged her to get her ...
-
ChinaDaily:White book on PAH patients released
2021-05-22
More than half of pulmonary arterial hypertension sufferers ...
-
WHO:New WHO Global Compact to speed up action to tackle diab
2021-05-22
The Compact was launched today at the Global Diabetes Summit...
-
PRNewswire:Bushu Pharma's Collaboration with Suzuken Group E
2021-05-22
KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishmen...
-
China trials mixing of CanSinoBIO's and Zhifei Longcom's COV
2021-04-20
Chinese researchers are testing the mixing of COVID-19 vacci...
-
China Pharma Expects Considerable Increase in Growth Opportu
2021-04-19
China Pharma Holdings, Inc., a specialty pharmaceutical comp...
-
BOSAL to open new manufacturing plant and R&D center in Shan
2021-03-29
BOSAL, a leading European supplier of energy and mobility in...
-
Coherent Biopharma Inks Strategic Partnership Agreement with
2021-03-29
On March 25, 2021, Coherent Biopharma and Roche Diagnostics ...
-
ASCO: Does Allogeneic Stem Cell Transplantation Still Have a
2020-05-20
Prognosis is less favorable in high-risk cases of chronic ly...
-
Nature: Gene-editing pipeline takes off
2020-05-15
Clinical trials of genome-editing agents — including CRISPR–...
-
Forbes: These Are The World's Largest Drug And Biotech Compa
2020-05-13
...
-
Forbes: Medtronic, Abbott, Thermo Fisher Are The World's Lar
2020-05-13
The 10 biggest healthcare companies in the world all climbed...
-
Bayer: Reading Genes for Better Therapies
2020-05-04
Bayer researchers scrutinize the anonymized DNA of thousands...
-
Alexion: Alexion Receives CHMP Positive Opinion for ULTOMIRI
2020-05-01
BOSTON--(BUSINESS WIRE)--May 1, 2020-- Alexion Pharmaceutica...
-
Medtronic: Three keys to unlocking Data-driven health care
2020-05-01
...
-
Amgen: Amgen Reports First Quarter 2020 Financial Results
2020-04-30
THOUSAND OAKS, Calif., April 30, 2020 /PRNewswire/ -- Amgen ...
-
McGill University: Better understanding of nature’s nanomach
2020-04-30
Many of the drugs and medicines that we rely on today are na...
-
GSK: GSK delivers strong Q1: sales £9.1 billion +19% AER, +1
2020-04-29
Sales growth reflects strong underlying performance and addi...
Industry Reports
-
2024 Global Life Sciences Sector Outlook
2024-05-31
With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro-economic drivers to guide their future growth. While the list of trends with wide-ranging global impact is broad, in this year, life sciences enterprises are paying particular attention to those more disruptive trends....
>>
-
2024 Health Care & Life Sciences Top Trends
2024-04-29
Share on Twitter Print Share by Email Share Back to top Artificial intelligence continues to be one of the most talked about business trends. Many of the AI technologies that health care and life sciences companies are adopting are largely untested from a legal perspective, creating gray areas that regulatory agencies are grappling with. AI innovations also offer opportunities for competitive advantage through the strategic management of intellectual property rights....
>>
-
A coming (r)evolution? Pharma industry outlook, trends and strategies for 2024
2024-02-13
A trio of outside forces will test the pharmaceutical industry’s resilience in the year ahead, catalyzing the industry’s continued evolution via breakthrough science and innovation of its customer engagement strategies....
>>
-
2024 Healthcare and Life Sciences Investment Outlook
2023-12-10
This in-depth examination of the healthcare and life sciences (HCLS) deal market explores how the major developments of 2023 have prepared the way for the year ahead. In this paper, we analyze how eight subsectors fared during another year of industry challenges and global instability, and how deal activity and market drivers could shape the 2024 investment landscape....
>>
-
2024 Outlook for Life Sciences GenAI, drug prices, economy likely to influence strategy
2023-12-06
Digital transformation, generative artificial intelligence (AI), and the adoption of virtual health/digital tools are the three trends most likely to impact medical device manufacturers in 2024, according to a survey of C-suite executives conducted by the Deloitte Center for Health Solutions....
>>
-
The world bank group:World Development Report 2022
2022-02-15
World Development Report 2022: Finance for an Equitable Recovery examines the central role of finance in the economic recovery from COVID-19. Based on an in-depth look at the consequences of the crisis most likely to affect low- and middle-income economies, it advocates a set of policies and measures to mitigate the interconnected economic risks stemming from the pandemic—risks that may become more acute as stimulus measures are withdrawn at both the domestic and global levels. Those policies include the efficient and transparent management of nonperforming loans to mitigate threats to financial stability, insolvency reforms to allow for the orderly reduction of unsustainable debts, innovations in risk management and lending models to ensure continued access to credit for households and businesses, and improvements in sovereign debt management to preserve the ability of governments to support an equitable recovery....
>>
-
Global Wellness Institute:The Global Wellness Economy-Looking Beyond COVID
2021-12-28
The Global Wellness Institute (GWI) defines wellness as the active pursuit of activities, choices,and lifestyles that lead to a state of holistic health. There are two important aspects to this definition. First, wellness is not a passive or static state, but rather an “active pursuit” that is associated with intentions, choices, and actions. Second, wellness is linked to holistic health – that is, it extends beyond physical health and incorporates many different dimensions, including physical, mental, emotional, spiritual, social, and environmental dimensions....
>>
-
Deloitte:Intelligent drug launch and commercial Optimising value through AI
2021-05-22
This is the fifth report in our Intelligent biopharma series, which explores the current and future potential of artificial intelligence (AI) across the biopharma value chain.1 This report focuses on how companies can use AI to improve drug launches and their commercial models....
>>
-
McKinsey & Company:Leap to the future of healthcare: Reinvent through business building
2021-05-22
Reinventing business models and building new sources of revenue have never been more important for the healthcare industry, especially as it seeks to improve lives and livelihoods. As we note in our article, “The great acceleration in healthcare: Six trends to heed,” business model reinvention is increasingly becoming essential to deliver greater value to stakeholders in the areas of quality, affordability, access, experience, and equity....
>>
-
The Lancet: Social innovation in global health: sparking location action
2020-05-02
Health innovation is often developed in response to local challenges, fueled from frontline health workers by unique needs and opportunities. Yet the power to scale up innovation is often vested in high-level authorities that have limited understanding of local contexts. How can innovation in global health be sparked? A growing social innovation in health movement shows that innovation is more effective when it emerges bottom-up from low-income and middle-income countries....
>>